7/2/2018Priority Review for Drug Registration: Import Drugs vs. Locally-made D...

6/29/2018Recent Official and Executive Moves

6/29/2018I-Mab Successfully Raised $220 Million in Series C Funding

6/29/2018NHC Official: SMIA May Introduce BMI Payment Standards Before Year-end

6/28/2018Bain Reportedly Near Deal to Acquire DSM Sinochem Pharma

6/28/2018CDE Solicits Feedbacks on Technical Guidelines for Clinical Trial of M...

6/28/2018Fresh Challenge for Chinese Investment in U.S. Biopharma

6/27/2018Ascletis and CR Pharma Enter Strategic Distribution Agreement for Gano...

6/26/2018CNDA Officials Pledge Accelerated Import Drug Registration in China

6/26/2018Domestically-listed Chinese Biopharma Cos Report Performance Guidance ...

6/26/2018Amyris and BGI to Set Up JV for Development of Health Products in Grea...

6/25/2018CDE Publishes Interim General Technical Requirements for Batch Product...

6/25/2018Recent Executive Moves

6/25/2018WuXi Biologics and Harbour BioMed Announce Strategic Partnership

6/22/2018Tot Biopharm Opens New Biologics Facility in Suzhou

6/21/2018China's Removal of Imported Drug Tariffs: Implications for Foreign and...

6/20/2018Wuxi Biologics Initiated Construction of Integrated ADC Solution Cente...

6/20/2018IQVia: Overview of Urban Chinese Hospital Drug Sales in 2017

6/20/2018IQVia: Overview of Chinese Urban Retail Pharmacy Market in 2017

6/20/2018Overview of Chinese In-licensing of Foreign Investigational New Drugs ...

6/20/2018MSF Challenges Gilead's Chinese Patent HCV Drug Velpatasvir

6/20/2018European Chamber Warns China over Uneven Market Access and Treatment f...

6/20/2018Sedor and Los Altos Enter Greater China License Agreement for CE-Melox...

6/20/2018Luye Pharma's Class 1.1 New Analgesic to Start Phase I Trial in China

6/19/2018Merck and Alibaba Health Announce Collaboration to Develop Patient-Cen...

6/19/2018Johnson & Johnson Launches J&J Institute for Asia Pacific Regi...

6/19/2018Alpha Biopharma Announces Series A Financing

6/19/2018MNCs Lose Top Talents to Booming Domestic Biopharma Startups

6/19/2018CITIC Capital Proposes To Acquire China Biologic for $3.65B

6/19/2018India Releases Study for Enhancing Access to the Chinese Pharma Market

Page:137/334 Total number of articles:10001: [First][<<] [135] [136] [137] [138] [139] [>>] [End]